5 Leading MMPR LP CEOs Weigh in on Important Rule Changes to Canada’s Cannabis Industry

Written by Alan Brochstein for CFA.

5Denis Arsenault, Neil Closner, Vic Neufeld, Terry Booth and Bruce Linton
This is a big month for Canada’s federal medical cannabis program, MMPR, as Health Canada must respond to the Allard ruling by August 24th, paving the way for home grow and possibly other changes.  The program, which was officially launched on April 1, 2014, is reaching critical mass, with over 53K registered patients as of March 31st and likely more than 70K at the end of July given the strong growth rates that we reported at the end of June.

MMPR has already evolved in many ways, perhaps the most significant of which was the inclusion of extracts, with the first license awarded last summer following the Smith case that mandated the program allow for cannabis derivatives. While most industry observers expect that Health Canada will permit some form of home growing by patients, there may be some other changes as well.  In order to gauge what the industry leaders expect, we asked several MMPR Licensed Producer CEOs to share their perspective.

Not surprisingly, all of the CEOs expect that home grow will be permitted. Denis Arsenault, CEO of Organigram (TSXV: OGI) (OTC: OGRMF), expects that patients with prescriptions will be able to to grow 6-8 plants, and he is also predicting that pharmacies will be able to dispense. Terry Booth, CEO of Aurora Cannabis (TSXV: ACB) (OTC: ACBFF), suggested that there would be home grow but with limits. He also expects to see changes to the Controlled Drug and Substance Act. Neil Closner, CEO of MedReleaf, expects the plant count to be limited.

Bruce Linton, CEO of Canopy Growth (TSX: CGC) (OTC: TWMJF), the parent of Tweed and Bedrocan Canada, thinks that the initial Health Canada move will be somewhat of a re-enabling of the prior system, MMAR, with corrections made in the future. He also believes that there could be further expansion in the forms of cannabis permitted for sale beyond dried flower and the current extracts. Finally,  Vic Neufeld, CEO of Aphria (TSXV: APH) (OTC: APHQF) expects some sort of designated grower status and believes that LPs may be the supplier of plant genetics for home growers. He also suggests that pharmacies could be added to distribution in order to combat the proliferation of illegal dispensaries.

Read full article Here.

About Brent

Hello, My name is Brent and I am a MMPR patient. I write articles for Dankr.ca and help build connections with the Toronto cannabis community. I am also the Content Manager, so message me if you would like to work with Dankr.ca.

Leave a Reply

Powered by Dragonballsuper Youtube Download animeshow